Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | PDE2A | O00408 | 7/20 | 0.36 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PAX2 | Q02962 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4819802 | 1.00 | LMNA (0.36) | LMNAALDH1A1SMN1; SMN2NPC1PDE2A | |
| SCHEMBL25616299 | 0.90 | PAX2 (0.39) | LMNAALDH1A1SMN1; SMN2PDE2AKDM4E | |
| SCHEMBL25616316 | 0.90 | PAX2 (0.39) | LMNAALDH1A1SMN1; SMN2PDE2AKDM4E | |
| SCHEMBL5183012 | 0.88 | LMNA (0.34) | LMNAALDH1A1SMN1; SMN2PDE2ATSHR | |
| SCHEMBL14416878 | 0.88 | PDE2A (0.37) | LMNAALDH1A1SMN1; SMN2PDE2ATSHR | |
| SCHEMBL974937 | 0.88 | KDM1A (0.39) | LMNAALDH1A1SMN1; SMN2PDE2AHSD17B10 | |
| SCHEMBL4817224 | 0.88 | ALDH1A1 (0.34) | LMNAALDH1A1SMN1; SMN2PDE2AKDM4E | |
| SCHEMBL8916786 | 0.88 | TSHR (0.40) | LMNAALDH1A1SMN1; SMN2NPC1PDE2A | |
| SCHEMBL4821987 | 0.88 | TSHR (0.40) | LMNAALDH1A1SMN1; SMN2NPC1PDE2A | |
| SCHEMBL23925376 | 0.87 | EGLN2 (0.46) | PDE2AEGLN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6297251-B1 | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID CO. | 2001-10-02 | — | — | US | claimed |
| EP-0975634-B1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2001-07-04 | — | — | EP | claimed |
| EP-0975634-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 2000-02-02 | — | — | EP | claimed |
| WO-1998046607-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 1998-10-22 | — | — | WO | claimed |
| US-8974806-B2 | Method for producing aqueous active substance compositions of active substances that are hardly soluble in water | BASF AKTIENGESELLSCHAFT (DE) | 2015-03-10 | — | — | US | disclosed |
| US-8741324-B2 | Liquid pesticide compositions | BASF SE (DE) | 2014-06-03 | — | — | US | disclosed |
| US-8728504-B2 | Process for solubilizing hydrophobic active ingredients in aqueous medium | BASF SE (DE) | 2014-05-20 | — | — | US | disclosed |
| EP-2676680-A1 | Use of hydrophobin polypeptides as penetration enhancers | BASF SE (DE) | 2013-12-25 | — | — | EP | disclosed |
| US-8497230-B2 | Solid crop protection agents containing polyalkoxylate, method for their production and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-07-30 | — | — | US | disclosed |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF SE (DE) | 2013-05-16 | — | — | US | disclosed |
| EP-1763300-B1 | USE OF ETHER GROUP-CONTAINING POLYMERS AS SOLUBILIZERS | BASF SE (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-20110312497-A1 | USE OF HYDROPHOBIN AS A SPREADING AGENT | BASF SE (DE) | 2011-12-22 | — | — | US | disclosed |
| WO-2006125647-A1 | METHOD FOR DETERMINING RESIDUES IN PLASTICS | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-30 | — | — | WO | disclosed |
| WO-2006087227-A2 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006002984-A1 | LIQUID PESTICIDE COMPOSITIONS | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-12 | — | — | WO | disclosed |
| US-6297251-B1 | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID CO. | 2001-10-02 | — | — | US | disclosed |
| EP-0975634-B1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | BASF AG (DE) | 2001-07-04 | — | — | EP | disclosed |
| US-6117876-A | Fungicidal trifluorophenyl-triazolopyrimidines | AMERICAN CYANAMID COMPANY (US) | 2000-09-12 | — | — | US | disclosed |
| EP-0975634-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998046607-A1 | FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES | AMERICAN CYANAMID COMPANY (US) | 1998-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312497-A1 | USE OF HYDROPHOBIN AS A SPREADING AGENT | PFN1, DSTN, CHN2 | LMNA 662/4885ALDH1A1 3404/4885SMN1; SMN2 3032/4885 |
| US-20130123108-A1 | ACTIVE SUBSTANCE COMPOSITION COMPRISING AT LEAST ONE NITROGEN ATOM-CONTAINING, HYPERBRANCHED POLYMER | NOS1, NOS3, NPSR1 | LMNA 1230/4885ALDH1A1 2770/4885SMN1; SMN2 927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.